Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans.

Haiman CA, Setiawan VW, Xia LY, Le Marchand L, Ingles SA, Ursin G, Press MF, Bernstein L, John EM, Henderson BE.

Cancer Res. 2007 Apr 15;67(8):3565-8.

2.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
3.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

4.

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE.

Hum Mol Genet. 2003 Oct 15;12(20):2679-92. Epub 2003 Aug 27.

PMID:
12944421
5.

Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.

Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE, Haiman CA.

Hum Mol Genet. 2004 Oct 15;13(20):2431-41. Epub 2004 Aug 18.

PMID:
15317758
6.

Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.

Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1021-5.

7.
8.

Potential differences in breast cancer risk factors based on CYP1A1 MspI and African-American-specific genotypes.

Zhu K, Hunter S, Payne-Wilks K, Sutcliffe C, Bentley C, Roland CL, Williams SM.

Ethn Dis. 2006 Winter;16(1):207-15.

PMID:
16599372
9.

Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.

Canter JA, Kallianpur AR, Parl FF, Millikan RC.

Cancer Res. 2005 Sep 1;65(17):8028-33.

10.

A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.

Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ.

Cancer Res. 1995 Sep 1;55(17):3757-8.

11.

Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations.

Haiman CA, Hsu C, de Bakker PI, Frasco M, Sheng X, Van Den Berg D, Casagrande JT, Kolonel LN, Le Marchand L, Hankinson SE, Han J, Dunning AM, Pooley KA, Freedman ML, Hunter DJ, Wu AH, Stram DO, Henderson BE.

Hum Mol Genet. 2008 Mar 15;17(6):825-34. Epub 2007 Dec 3.

PMID:
18056155
12.

A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.

Setiawan VW, Cheng I, Stram DO, Giorgi E, Pike MC, Van Den Berg D, Pooler L, Burtt NP, Le Marchand L, Altshuler D, Hirschhorn J, Henderson BE, Haiman CA.

Cancer Res. 2006 Dec 15;66(24):12019-25.

13.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
14.

Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.

Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T.

Carcinogenesis. 2006 Jul;27(7):1377-85. Epub 2006 Jan 6.

PMID:
16399771
15.

Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover RN, Hunter DJ, Husing A, Kaaks R, Kolonel LN, Le Marchand L, Linseisen J, McCarty CA, Overvad K, Panico S, Purdue MP, Stram DO, Stevens VL, Trichopoulos D, Willett WC, Yuenger J, Thun MJ.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539.

16.

A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.

Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, Altshuler D, Haiman CA.

Cancer Res. 2005 Aug 15;65(16):7516-22.

17.

Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W.

Pharmacogenet Genomics. 2006 Apr;16(4):237-43.

PMID:
16538170
18.

Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.

Stevens VL, Rodriguez C, Pavluck AL, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1226-8.

19.

Association of polymorphisms of angiogenesis genes with breast cancer.

Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, Skaar T, Flockhart DA.

Breast Cancer Res Treat. 2008 Sep;111(1):157-63. Epub 2007 Sep 20.

PMID:
17891484
20.

5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer.

Wang J, John EM, Ingles SA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2748-54. doi: 10.1158/1055-9965.EPI-08-0439.

Supplemental Content

Support Center